Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Research (Washington, D.C.)|October 5, 2023
Remodeling Tumor Immune Microenvironment by Using Polymer-Lipid-Manganese Dioxide Nanoparticles with Radiation Therapy to Boost Immune Response of Castration-Resistant Prostate CancerAbdulmottaleb E Zetrini, HoYin Lip, Azhar Z Abbasi, et al.Advanced Healthcare Materials|August 23, 2025
A Novel Brain Penetrable Nanocarrier Delivers Brain-Derived Neurotrophic Factor to Treat Alzheimer's DiseaseLily Yi Li, Elliya Park, Chunsheng He, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentXiao Yu Wu, Lily Yi Li, Elliya Park, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|April 25, 2015
Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancerAzhar Z Abbasi, Preethy Prasad, Ping Cai, et al.Acta Pharmacologica Sinica|April 27, 2018
Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examplesRui Xue Zhang, Jason Li, Tian Zhang, et al.Journal of Nanobiotechnology|May 18, 2026
Multitargeted nanoparticles inhibit cancer invasion by disrupting cancer-associated fibroblast-tumor cell crosstalk and modulating collagen pattern and EMTLiting Wang, Pei Zhi, Ibrahim Alradwan, et al.Nanotoxicology|June 7, 2024
Evaluation of the biodistribution and preliminary safety profile of a novel brain-targeted manganese dioxide-based nanotheranostic system for Alzheimer's diseaseLily Yi Li, Elliya Park, Chunsheng He, et al.Molecular Pharmaceutics|May 17, 2014
Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor modelAdam J Shuhendler, Preethy Prasad, Rui Xue Zhang, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|January 17, 2016
Polymer-lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin-mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tumorRui Xue Zhang, Ping Cai, Tian Zhang, et al.Journal of the National Cancer Institute|September 22, 2018
Combining Tumor Microenvironment Modulating Nanoparticles with Doxorubicin to Enhance Chemotherapeutic Efficacy and Boost Antitumor ImmunityMohammad Ali Amini, Azhar Z Abbasi, Ping Cai, et al.Pageof 5